Literature DB >> 11053437

Evidence for direct interaction between Sprouty and Cbl.

E S Wong1, J Lim, B C Low, Q Chen, G R Guy.   

Abstract

Sprouty (SPRY) was first identified in a genetic screen in Drosophila as an antagonist of fibroblast and epidermal growth factor receptors and Sevenless signaling, seemingly by inhibiting the receptor tyrosine kinase (RTK)/Ras/MAPK pathway. To date, four mammalian Sprouty genes have been identified; the primary sequences of the gene products share a well conserved cysteine-rich C-terminal domain with their Drosophila counterpart. The N-terminal regions do not, however, exhibit a large degree of homology. This study was aimed at identifying proteins with which human SPRY2 (hSPRY2) interacts in an attempt to understand the mechanism by which Sprouty proteins exert their down-regulatory effects. Here, we demonstrate that hSPRY2 associates directly with c-Cbl, a known down-regulator of RTK signaling. A short sequence in the N terminus of hSPRY2 was found to bind directly to the Ring finger domain of c-Cbl. Parallel binding was apparent between the Drosophila homologs of Sprouty and Cbl, with cross-species associations occurring at least in vitro. Coexpression of hSPRY2 abrogated an increase in the rate of epidermal growth factor receptor internalization induced by c-Cbl, whereas a mutant hSPRY2 protein unable to bind c-Cbl showed no such effect. Our results suggest that one function of hSPRY2 in signaling processes downstream of RTKs may be to modulate c-Cbl physiological function such as that seen with receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053437     DOI: 10.1074/jbc.M006945200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins.

Authors:  James E Egan; Amy B Hall; Bogdan A Yatsula; Dafna Bar-Sagi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

2.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

3.  Feasibility of using gene expression analysis to study canine soft tissue sarcomas.

Authors:  Jennifer A Mahoney; Julie C Fisher; Stacey A Snyder; Marlene L Hauck
Journal:  Mamm Genome       Date:  2010-11-13       Impact factor: 2.957

4.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

5.  Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

Authors:  Kaisa Haglund; Mirko H H Schmidt; Esther Sook Miin Wong; Graeme R Guy; Ivan Dikic
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

6.  HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.

Authors:  Francis Edwin; Kimberly Anderson; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

7.  Cbl controls EGFR fate by regulating early endosome fusion.

Authors:  Gina D Visser Smit; Trenton L Place; Sara L Cole; Kathryn A Clausen; Soumya Vemuganti; Guojuan Zhang; John G Koland; Nancy L Lill
Journal:  Sci Signal       Date:  2009-12-22       Impact factor: 8.192

8.  Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.

Authors:  Esther Sook Miin Wong; Chee Wai Fong; Jormay Lim; Permeen Yusoff; Boon Chuan Low; Wallace Y Langdon; Graeme R Guy
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

9.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.

Authors:  Qingxiang Sun; Rebecca A Jackson; Cherlyn Ng; Graeme R Guy; J Sivaraman
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.